BioLineRx (BLRX) had the highest return between July 1, 2011 and July 31, 2011 by a US stock, returning 50,682.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
BioLineRx (BLRX) | 7/1/2011 - 7/31/2011 | 50,682.57% |
QXO (QXO) | 7/1/2011 - 7/31/2011 | 1,300% |
InnovAge (INNV) | 7/1/2011 - 7/31/2011 | 566.67% |
Cardiff Oncology (CRDF) | 7/1/2011 - 7/31/2011 | 356.25% |
Singularity Future Technology (SGLY) | 7/1/2011 - 7/31/2011 | 289.73% |
OLB (OLB) | 7/1/2011 - 7/31/2011 | 265.85% |
Red Cat (RCAT) | 7/1/2011 - 7/31/2011 | 212.5% |
Dolphin Entertainment (DLPN) | 7/1/2011 - 7/31/2011 | 179.41% |
Harrow Health (HROW) | 7/1/2011 - 7/31/2011 | 133.33% |
Nephros (NEPH) | 7/1/2011 - 7/31/2011 | 113.33% |
MEI Pharma, Inc Common Stock (LITS) | 7/1/2011 - 7/31/2011 | 112.75% |
SUI (SUIG) | 7/1/2011 - 7/31/2011 | 108.33% |
Aemetis (AMTX) | 7/1/2011 - 7/31/2011 | 91.3% |
Cocrystal Pharma (COCP) | 7/1/2011 - 7/31/2011 | 84.86% |
DLH (DLHC) | 7/1/2011 - 7/31/2011 | 81.58% |
Algorhythm (RIME) | 7/1/2011 - 7/31/2011 | 72.41% |
Digital Turbine (APPS) | 7/1/2011 - 7/31/2011 | 70.45% |
FlexShopper (FPAY) | 7/1/2011 - 7/31/2011 | 69.7% |
Netcapital (NCPL) | 7/1/2011 - 7/31/2011 | 66.67% |
Predictive Oncology (POAI) | 7/1/2011 - 7/31/2011 | 61.62% |
Ryvyl (RVYL) | 7/1/2011 - 7/31/2011 | 50% |
Heron Therapeuti (HRTX) | 7/1/2011 - 7/31/2011 | 50% |
Biocardia (BCDA) | 7/1/2011 - 7/31/2011 | 50% |
eGain (EGAN) | 7/1/2011 - 7/31/2011 | 49.02% |
Cosmos Health (COSM) | 7/1/2011 - 7/31/2011 | 47.06% |
